Microbot Medical Inc (MBOT)
NASDAQ:MBOT
Total Valuation
Microbot Medical has a market cap or net worth of $157.82M. The enterprise value is $104.04M.
Market Cap$157.82M
Enterprise Value$104.04M
Share Statistics
Microbot Medical has 67,158,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding67,158,040
Owned by Insiders0.20%
Owned by Institutions2.53%
Financial Efficiency
Microbot Medical’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -18.80%.
Return on Equity (ROE)-0.17
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-18.80%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee0.00
Profits Per Employee-657.10K
Employee Count20
Asset Turnover0.00
Inventory Turnover0.08
Valuation Ratios
The current PE Ratio of Microbot Medical is ―. Microbot Medical’s PEG ratio is 0.12.
PE Ratio―
PS Ratio0.00
PB Ratio1.18
Price to Fair Value1.18
Price to FCF-6.99
Price to Operating Cash Flow-11.79
PEG Ratio0.12
Income Statement
In the last 12 months, Microbot Medical had revenue of 0.00 and earned -13.14M in profits. Earnings per share was -0.29.
Revenue0.00
Gross Profit-47.00K
Operating Income-14.74M
Pretax Income-13.14M
Net Income-13.14M
EBITDA-14.70M
Earnings Per Share (EPS)-0.29
Cash Flow
In the last 12 months, operating cash flow was -13.05M and capital expenditures -60.00K, giving a free cash flow of -13.11M billion.
Operating Cash Flow-13.05M
Free Cash Flow-13.11M
Free Cash Flow per Share-0.20
Dividends & Yields
Microbot Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.57
52-Week Price Change42.42%
50-Day Moving Average2.29
200-Day Moving Average2.57
Relative Strength Index (RSI)46.30
Average Volume (3m)1.89M
Important Dates
Microbot Medical upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Microbot Medical as a current ratio of 23.33, with Debt / Equity ratio of 1.12%
Current Ratio23.33
Quick Ratio23.16
Debt to Market Cap<0.01
Net Debt to EBITDA0.21
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Microbot Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Microbot Medical EV to EBITDA ratio is -6.02, with an EV/FCF ratio of -6.76.
EV to Sales0.00
EV to EBITDA-6.02
EV to Free Cash Flow-6.76
EV to Operating Cash Flow-6.79
Balance Sheet
Microbot Medical has $78.59M in cash and marketable securities with $865.00K in debt, giving a net cash position of $77.73M billion.
Cash & Marketable Securities$78.59M
Total Debt$865.00K
Net Cash$77.73M
Net Cash Per Share$1.16
Tangible Book Value Per Share$1.69
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Microbot Medical is $7.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.50
Price Target Upside219.15% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―